Log in
Enquire now
‌

US Patent 11597759 Multispecific antibodies that target HIV GP120 and CD3

OverviewStructured DataIssuesContributors

Contents

Is a
Patent
Patent
0

Patent attributes

Patent Applicant
Gilead Sciences
Gilead Sciences
0
Current Assignee
Gilead Sciences
Gilead Sciences
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
115977590
Date of Patent
March 7, 2023
0
Patent Application Number
168679240
Date Filed
May 6, 2020
0
Patent Citations
‌
US Patent 10336818 Fc variants with altered binding to FcRn
‌
US Patent 10087239 Broadly neutralizing human immunodeficiency virus type 1 (HIV-1) GP120-specific monoclonal antibody
0
‌
US Patent 10184000 Optimized Fc variants and methods for their generation
0
‌
US Patent 10584176 Fc variants with increased affinity for FcγRIIc
Patent Primary Examiner
‌
Jeffrey S. Parkin
0
CPC Code
‌
C07K 16/1063
0
‌
C07K 16/2809
0

Multispecific antibodies (e.g., bispecific antibodies) that bind to HIV gp120 and CD3 are disclosed. Also disclosed are methods of using such antibodies to treat or prevent HIV infection.

Timeline

No Timeline data yet.

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more entities like US Patent 11597759 Multispecific antibodies that target HIV GP120 and CD3

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.